Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rank in Stocks #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Share Price
$0.07600875
Last synced: 2024-11-20
Market Cap
$2.06M
Change (1 day)
-0.51%
Change (1 year)
0.00%
Country
FR
Trade Quantum Genomics S.A. (ALQGC)

Category

Stock split history for Quantum Genomics S.A. (ALQGC)
Quantum Genomics S.A. stock (symbol: ALQGC) underwent a total of 1 stock splits.
The most recent stock split occurred on Dec 13, 2013.
One ALQGC share bought prior to Dec 13, 2013 would equal to 0.055555555555556 ALQGC shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2013-12-13 1:18 x0.055555555555556 x0.055555555555556
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE